US pharmacy sues GLP-1 makers for ‘restricting competition’

The lawsuit claims the companies “forestalled all competition” for GLP-1 medicines (Shutterstock)
Molly Bowcott

Read more by Molly Bowcott

Molly Bowcott joined C+D as a digital reporter in October 2024 after graduating from a master’s in journalism at City, University of London. She previously worked as a news reporter at the U.S. Sun, covering business, politics and money.

Latest from Business

More from News